Literature DB >> 28007718

Correction factor to improve agreement between point-of-care and laboratory International Normalized Ratio values.

Stacy A Johnson1,2, Sara R Vazquez3, Ryan Fleming3, Michael J Lanspa4.   

Abstract

PURPOSE: Results of a research project to quantify and improve the accuracy of point-of-care (POC) International Normalized Ratio (INR) values are reported.
METHODS: The accuracy of POC INR values relative to laboratory-measured INR values was retrospectively assessed in a cohort of patients with same-day INR determinations by both methods. Univariate linear regression was performed to derive a correction factor for POC INR values of >3; this correction factor was validated in a second cohort.
RESULTS: In the derivation cohort (259 patients and 344 paired INR results), agreement of POC values with corresponding laboratory INR values at two specified thresholds (±15% and ±25%) was 51.2% and 66.6%, respectively; for POC INR values of >3 (n = 205), agreement was lower (24.9% and 44.9%, respectively). Univariate linear regression yielded a coefficient of 0.77 (95% confidence interval, 0.76-0.79; p < 0.001). Applying a correction factor of 0.8 to POC INR values in a validation cohort (169 patients and 209 paired INR values) significantly improved the accuracy of POC INR values of >3 relative to laboratory values (from 7% to 71.1% at the lower threshold and from 23.5% to 88.8% at the higher threshold, p < 0.0001 for both comparisons).
CONCLUSION: Agreement between POC and laboratory INR results in one institution was poor, especially when POC INR values exceeded 3. Application of an institution-specific correction factor to POC INR values of >3 improved agreement with laboratory INR results but would not have significantly reduced differences in protocol-based warfarin dosage adjustments.
Copyright © 2017 by the American Society of Health-System Pharmacists, Inc. All rights reserved.

Entities:  

Keywords:  International Normalized Ratio; correlation study; point-of-care systems; warfarin

Mesh:

Substances:

Year:  2016        PMID: 28007718     DOI: 10.2146/ajhp150813

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  1 in total

1.  Evaluation of point-of-care International Normalized Ratio in sickle cell disease.

Authors:  Syeda Rahman; Andrew Srisuwananukorn; Robert E Molokie; Michel Gowhari; Franklin Njoku; Faiz Ahmed Hussain; James Lee; Edith A Nutescu; Victor R Gordeuk; Santosh L Saraf; Jin Han
Journal:  Res Pract Thromb Haemost       Date:  2021-05-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.